Ali Shahraki

Dr. Ali Shahraki


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2020 in Shiraz E-Medical Journal
Verified
Journal Article
Open access
PDF file
MMMohammad Ali Mirshekar
Mohammad Ali Mirshekar
SMSomayeh Miri
Somayeh Miri
ASAli Shahraki
Ali Shahraki
Exposure to herbicide paraquat (PQT) is a potential risk factor for cognitive impairment. Many cognitive behaviors, including spatial memory, passive avoida ...

5 March 2012 in Health Scope
Verified
Journal Article
Closed access
PDF file
ASAli Shahraki
Ali Shahraki
MRMehdi Ravandeh
Mehdi Ravandeh
Comparative Survey on the Essential Oil Composition and Antioxidant Activity of Aqueous Extracts From Flower and Stem of Achillea Wilhelmsii From Taftan (Southeast of Iran) - Health Scope - - DOCS

15 February 2021 in Behavioural Pharmacology
Verified
Journal Article
Closed access
THTahereh Hemati
Tahereh Hemati
MAMehdi Abbasnejad
Mehdi Abbasnejad
MMMahtab Mollashahi
Mahtab Mollashahi
SESaeed Esmaeili-Mahani
Saeed Esmaeili-Mahani
ASAli Shahraki
Ali Shahraki
The present study was designed to evaluate the effect of plant bioactive compound methyl jasmonate on learning and memory, anxiety-like behaviors, and brain oxidative stress in rats. It has been indicated that methyl jasmonate stimulates calcium-binding protein expression and increases intracellular calcium (Ca2+). Therefore, we investigated the potential role of L-type calcium channel on methyl jasmonate effects. The animals were intracerebroventriculary (i.c.v.) injected with different doses of methyl jasmonate (0.5, 2.5, and 5 µg/rat). L-type calcium channel blocker (nifedipine 5 µg/rat, i.c.v.) was injected 30 min before methyl jasmonate (5 µg/rat). Shuttle box apparatus was used to evaluate passive avoidance memory. Anxiety-like behaviors were assessed by open field and elevated plus maze tests. Lastly, oxidative stress-related indices were assessed in hippocampus and prefrontal cortex. The data showed that methyl jasmonate dose-dependently could improve passive avoidance learning and memory and reduce anxiogenic behaviors. The methyl jasmonate effects were significantly prevented by nifedipine. Furthermore, central microinjection of methyl jasmonate significantly decreased hydrogen peroxide concentration, and increased reactive oxygen species scavenger activity (catalase and peroxide enzymes) in rats’ hippocampus as well as prefrontal cortex. Indeed, the results indicated that the beneficial effects of methyl jasmonate on learning and memory and anxiety might be partly associated with L-type calcium channel and partly on the inhibition of oxidant indices.

31 December 2025 in Brain Research
Verified
Journal Article
Closed access
HBHaniyeh Soheil Beygi
Haniyeh Soheil Beygi
ASAli Shahraki
Ali Shahraki
RSRoghayeh Sheervalilou
Roghayeh Sheervalilou

25 June 2016 in Shiraz E-Medical Journal
Verified
Journal Article
Open access
PDF file
ASAli Shahraki
Ali Shahraki
RSRoodabe Sarabandi
Roodabe Sarabandi
MKMohsen Kianpour
Mohsen Kianpour
ZZZahra Zakeri
Zahra Zakeri
Background: Various factors, including genetic, psychological, environmental, and immune dysfunction, may contribute to susceptibility to schizophrenia. Due to several reports regarding abnormal cytokine production, abnormal cytokine concentrations and their receptors in peripheral blood and cerebrospinal fluid, activation of the inflammatory response system, and altered levels of different cytokines in acute schizophrenia have been studied in recent years. Objectives: The purpose of this study was to examine interleukin-6 (IL-6) and IL-23 levels in schizophrenic patients versus those of healthy controls. Patients and Methods: In this case–control study, serum levels of IL-6 and IL-23 of 30 schizophrenic patients and 20 age- and gender-matched healthy controls were measured using an enzyme-linked immunosorbent assay (ELISA). The serum levels of these cytokines were measured in schizophrenic patients experiencing their first episode who had not taken any psychotic drugs for at least 2 months prior to the study. Statistical analysis was performed using SPSS software, version 17. IL levels showed a non-Gaussian distribution. The statistical analysis was performed using appropriate statistical tests, including the Kruskal-Wallis or Mann–Whitney test. Results: Serum IL-23 levels of schizophrenic patients were significantly higher (696 ± 132 pg/mL) than those of the control subjects (313 ± 33 pg/mL) (P = 0.007). Serum IL-6 levels of the schizophrenic patients were also significantly higher than those of the controls (5.28 ± 1.1 and 2.54 ± 0.32 pg/mL, respectively; P = 0.01). Conclusions: These findings indicate that immune system activation might be involved in the pathophysiology of schizophrenia. Keywords: Schizophrenia; Immune System; Interleukin-6; Interleukin-23

28 February 2016 in Shiraz E-Medical Journal
Verified
Journal Article
Open access
PDF file
SASamaneh Khazaei Asl
Samaneh Khazaei Asl
ASAli Shahraki
Ali Shahraki
ZZZahra Zakeri
Zahra Zakeri
Background: Dermatomyositis (DM) and polymyositis (PM) are common forms of idiopathic inflammatory myopathy which are characterized by muscle inflammation with an unknown cause. Immune cells infiltrate myofibrils and endomysial capillaries, which leads to damage of muscle fibers through the production of humoral factors and different cytokines. Objectives: Increased IL-18 and IL-6 serum levels have been reported in a variety of autoimmune diseases, including rheumatoid arthritis and inflammatory bowel disease. The purpose of this study was to evaluate IL-18 and IL-6 serum levels in DM and PM patients compared to a healthy control group. Patients and Methods: In this cross-sectional study, 15 patients with DM, 5 patients with PM, and 20 healthy control subjects were recruited. The levels of serum IL-18 and IL-6 in patients and control groups were measured by using ELISA assay. Blood tests were taken to determine the levels of C-reactive protein (CRP) and creatine kinase (CK) and were measured by standard methods. Statistical analyses were performed using the Mann-Whitney U-test with a non-Gaussian population using SPSS 19 software. Results: IL-18 levels were significantly higher in DM patients and PM patients before treatment compared to healthy control subjects (P = 0.001, P = 0.01, respectively). There were no significant differences between DM and PM patients before treatment with healthy controls for IL-6 serum levels (P = 0.51, P = 0.43, respectively). Conclusions: Serum IL-18 contributes to the immunopathogenesis of DM and PM and would be a useful marker for the diagnosis and treatment of diseases. IL-6 has a less pivotal role in the pathology of DM and PM. Keywords: Dermatomyositis; Polymyositis; Interleukin-18; Interleukin-6